|
|
Analysis of off-label use of Caffeine Citrate Injection in Neonatology Department of our hospital |
WU Minzhi WANG Ying SI Tubing |
Department of Pharmacy, the Third Affiliated Hospital of Guangzhou Medical University, Guangdong Province, Guangzhou 510150, China |
|
|
Abstract Objective To investigate and analyze the off-label use of Caffeine Citrate Injection among inpatients in Neonatology Department of the Third Affiliated Hospital of Guangzhou Medical University (“our hospital” for short), to provide reference for rational use of medicine in clinic. Methods The medical records of hospitalized children who received Caffeine Citrate Injection in Neonatology Department of our hospital from January to December 2017 were randomly selected to analyze the off-label use of Caffeine Citrate Injection. Results A total of 253 medical records of hospitalized children were taken, it was found that the off-label use of Caffeine Citrate Injection was common, the main manifestations were over indication, over-applicable population, inconsistence of usage, dosage and medication course of treatment with the instructions. Conclusion It is necessary to pay close attention to the situation of the off-label use in clinical medication, carry out intervention and feedback timely, and gradually standardize the behavior of the off-label use in clinical medication, so as to promote rational drug use.
|
|
|
|
|
[1] 陈尧,周宏灏.咖啡因体内代谢及其应用的研究进展[J].生理科学进展,2010,41(4):256-260.
[2] 杜立中.早产儿呼吸暂停的药物治疗[J].中国实用儿科杂志,2015,30(2):88-92.
[3] Jung K,LePendu P,Chen WS,et al. Automated detection of off-label drug use [J]. PLoS One,2014,9(2):e89324.
[4] 许景林,王瑞泉,陈冬梅.枸橼酸咖啡因与氨茶碱治疗早产儿原发性呼吸暂停的比较[J].中国当代儿科杂志,2014, 16(11):1129-1132.
[5] 齐卫斌,魏彦敏,翟娜,等.预防性持续低剂量咖啡因治疗超低出生体质量儿呼吸暂停疗效观察[J].临床合理用药杂志,2015,8(1):46-47.
[6] Henderson-Smart DJ,De Paoli AG. Methylxanthine treatment for apnoea in preterm infants [J]. Cochrane Database Syst Rev,2010(12):CD000140.
[7] 吴永芳,包蕾.高剂量咖啡因应用于极低出生体质量儿的研究进展[J].儿科药学杂志,2017,23(6):56-58.
[8] 李贤伟,周红瀛,李静.早期或晚期咖啡因治疗早产儿呼吸暂停临床效果的Meta分析[J].中国新生儿科杂志,2016, 31(5):370-374.
[9] Nagasato A,Nakamura M,Kamimura H. Comparative Study of the Efficacy and Safety of Caffeine and Aminophylline for the Treatment of Apnea in Preterm Infants [J]. Yakugaku Zasshi,2018,138(2):237-242.
[10] Schoen K,Yu T,Stockmann C,et al. Use of methylxanthine therapies for the treatment and prevention of apnea of prematurity [J]. Paediatr Drugs,2014,16(2):169-177.
[11] Skouroliakou M,Bacopoulou F,Markantonis SL. Caffeine versus theophylline for apnea of prematurity:a randomised controlled trial [J]. J Paediatr Child Health,2009,45(10):587-592.
[12] Bucher HU,Duc G. Does caffeine prevent hypoxaemic episodes in premature infants? A randomized controlled trial [J]. Eur J Pediatr,1988,147(3):288-291.
[13] Henderson-Smart DJ,De Paoli AG. Prophylactic methylxanthine for prevention of apnoea in preterm infants [J]. Cochrane Database Syst Rev,2010(12):CD000432.
[14] 柳国胜.新生儿呼吸暂停[J].实用儿科临床杂志,2007,(2):89-92.
[15] 张李霞,徐景武,高平明.枸橼酸咖啡因在早产儿撤机中的应用[J].热带医学杂志,2017,17(4):514-516,529.
[16] 魏怀俊.枸橼酸咖啡因与氨茶碱治疗早产儿原发性呼吸暂停的效果及安全性比较[J].中国当代医药,2016, 23(14):101-104.
[17] 林开颜,蔡琍璇,刘杨,等.枸橼酸咖啡因治疗早产极低体重儿呼吸暂停的效果[J].广东医学,2016,37(2):292-294.
[18] 董卓亚,叶朝辉.枸橼酸咖啡因在早产儿呼吸暂停的应用[J].现代实用医学,2015,27(3):385-386.
[19] 陈永法,黄丽.我国超说明书用药现象探析[J].中国药房,2013,24(13):1162-1164.
[20] 唐蕾,韦炳华,何秋毅,等.超说明书用药的现状及其法律风险[J].中国药房,2014,25(45):4225-4228.
[21] 利亭婷,周婧,银雪艳,等.雷公藤多苷超说明书用于儿童的用药分析[J].中国医院药学杂志,2018,38(6):675-678.
[22] 童艳丽,梅清华,林壮民.我院门诊二甲双胍超说明书用药调查分析[J].中国当代医药,2016,23(1):158-160.
[23] 王颖,谭湘萍,司徒冰.我院超说明书用药的分级管理研究[J].中国药房,2017,28(10):1306-1310. |
|
|
|